<DOC>
	<DOCNO>NCT02184065</DOCNO>
	<brief_summary>Observational study evaluate efficacy safety meloxicam ( MobicoxÂ® ) Mexican population rheumatic disease</brief_summary>
	<brief_title>Observational Study Meloxicam Mexican Patients With Rheumatic Diseases</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Age 12 old rheumatologic disease Hypersensitivity meloxicam Hypersensitivity Nonsteroidal antiinflammatory drug ( NSAIDS ) History asthma , angioedema urticaria secondary NSAIDS Pregnancy lactation Recent current history peptic ulcer disease , severe renal failure severe hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>